News Center
With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.
27
2026
-
04
Tracing the Footsteps of Mountains, Waters, and Sages While Exploring New Growth Opportunities in the Pharmaceutical Industry — Industry Leaders Gather in the “Spring City,” as Keyyuan Pharmaceutical’s Subsidiary Unveils Several Major New Products
Classification：
Corporate News
4 month 24 Date to 27 Day, “Tracing the Footsteps of a Mountain, a River, and a Sage” Tracing the Origins: One Gold, One Award, One Hall “The themed event was successfully held in Jinan. This event was jointly organized by the Retail Pharmacy Branch and the Independent Pharmacy Branch of the China Pharmaceutical Materials Association.” 2026 The important opening of the work conference officially kicks off. “ Climbing Mount Tai ・ Visiting the Confucius Temple ・ Embark on a New Journey —— Hongjitang Pharmaceutical & Shengsheng Pharmaceutical’s Journey into Traditional Chinese Culture ・ Jointly Exploring Non-Pharmacological Incremental Gains ” The series of events has officially kicked off. Hundreds of representatives from the China Association for Medical Supplies, the Retail Pharmacy Branch, the Independent Pharmacy Branch, and pharmaceutical chain enterprises across the country have gathered in the Qilu region to discuss industry development, explore opportunities for market growth, and embark on a new journey of integrating culture with the industry.
During the four-day visit to Shandong, the conference delegates made a special trip to Shandong Keyuan Pharmaceutical Co., Ltd. (stock code: 301281.SZ ) Visit and inspection of the digital and intelligent injection manufacturing plant of the subsidiary, Shandong Linuo Pharmaceutical. As 2026 In recent years, Jinan City has launched smart factory initiatives and Shandong Province has promoted green, low-carbon, high-quality development projects. Lino Pharmaceutical’s injectable digital intelligence factory leverages digital twins, 5G、 AI Visual inspection, AGV Cutting-edge technologies such as smart logistics have established a modern production benchmark that integrates automated manufacturing, intelligent control, and end-to-end traceability. The guests then delved into lyophilized powder for injection, BFS During a site visit to the intelligent production line, participants observed end-to-end operations spanning raw-material processing, precision filling, aseptic manufacturing, intelligent light inspection, and logistics distribution, and commended the facility’s advanced level of smart manufacturing, robust quality-control system, and commitment to green production.
At the networking gala, Linuo Pharmaceutical made a major announcement, unveiling several of its core new products, such as: “Diphenhydramine Hydrochloride Tablets, Betahistine Hydrochloride Tablets, Ferrous Succinate Oral Solution, Minoxidil Topical Solution, Ambroxol Hydrochloride Drops,” among others, as well as household staple medications such as “Isosorbide Dinitrate Spray and Amlodipine Paste,” cover multiple clinically essential therapeutic areas—including cardiovascular and cerebrovascular diseases, allergy management, vertigo, iron supplementation, hair growth, respiratory conditions, and oral health—thereby comprehensively enriching the product portfolio of retail pharmacies.
As a wholly owned subsidiary of the listed company Keyuan Pharmaceutical, the company has been deeply engaged in the chronic disease pharmaceutical sector for more than two decades. Leveraging its integrated API–formulation capabilities, end-to-end digital and intelligent manufacturing, and comprehensive quality control across the entire value chain, it continuously develops high-quality, premium medicines. The products unveiled this time are precisely tailored to meet the needs of retail pharmacies for medications used to treat common and chronic conditions as well as for household stockpiles. Moving forward, the company will collaborate with partners nationwide to provide consumers with higher-quality, more convenient medication options and jointly tap into the incremental growth opportunities in the pharmaceutical retail market.
This event has not only established a high-quality platform for exchange and collaboration within the pharmaceutical industry, but also underscored the robust strengths of Shandong’s pharmaceutical sector in intelligent manufacturing, brand leadership, and cultural empowerment. Moving forward, Keyuan Pharmaceutical and Linuo Pharmaceutical will continue to work closely with the China Association of Pharmaceutical Materials and pharmaceutical chain partners nationwide, taking culture as the soul, quality as the foundation, and innovation as the driving force, to deepen their presence in the pharmaceutical retail market, expand non-pharmaceutical growth opportunities, jointly promote high-quality industry development, and safeguard public health.
Related news
2026-05-18
On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.
ADD：#30766 Jingshidong Road, Linuo High-tech Park, Jinan, Shandong Province, P. R. China